Cryptococcus neoformans. II. Phagocytosis by human leukocytes.
about
Cryptococcus neoformans: Tripping on Acid in the PhagolysosomeCryptococcal interactions with the host immune system.Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans.History of medical mycology in the united states.Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen.In vitro interactions of immune lymphocytes and Cryptococcus neoformans.A sensitive high-throughput assay for evaluating host-pathogen interactions in Cryptococcus neoformans infectionPhagocytosis of Cryptococcus neoformans by alveolar macrophages.Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificityCryptococcus neoformans IV. The Not-So-Encapsulated Yeast.Capsule size of Cryptococcus neoformans: control and relationship to virulence.In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformansIntracellular fate of Cryptococcus neoformans.Genetic study of oxygen resistance and melanization in Cryptococcus neoformans.Differential localization of complement component 3 within the capsular matrix of Cryptococcus neoformans.Characterization of a suppressor factor that regulates phagocytosis by macrophages in murine cryptococcosis.A yeast under cover: the capsule of Cryptococcus neoformans.Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils.Structure and biological activities of acapsular Cryptococcus neoformans 602 complemented with the CAP64 geneAcute lethal toxicity following passive immunization for treatment of murine cryptococcosisRole of phagocytosis in the virulence of Cryptococcus neoformans.Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans.UDP glucuronate decarboxylase and synthesis of capsular polysaccharide in Cryptococcus neoformans.Immediate hypersensitivity to Cryptococcus neoformansCryptococcus neoformans. 3. Inhibition of phagocytosis.Galactoxylomannans of Cryptococcus neoformans.Strain variation in antiphagocytic activity of capsular polysaccharides from Cryptococcus neoformans serotype AInduction of a macrophage-suppressive lymphokine by soluble cryptococcal antigens and its association with models of immunologic tolerance.Modification of macrophage phagocytosis in murine cryptococcosis.Role of dendritic cell-pathogen interactions in the immune response to pulmonary cryptococcal infection.Histone deacetylases inhibitors effects on Cryptococcus neoformans major virulence phenotypesAutomated analysis of cryptococcal macrophage parasitism using GFP-tagged cryptococci.Influence of opsonization conditions on C3 deposition and phagocyte binding of large- and small-capsule Cryptococcus neoformans cells.What makes Cryptococcus neoformans a pathogen?
P2860
Q26765874-A2DC185F-C642-4CA7-B173-C3AF5EBCBBCFQ30387948-66637F86-32FF-498A-B35E-20CB8D70C034Q30424017-5920EAE3-382B-477D-9DC2-1EF3CECD87A5Q30452877-B0FE17F4-087B-4E94-8800-D2163C62446DQ33616470-7378A4CA-4463-464D-ACFF-3BCFB8799730Q33912930-FEC425FD-9C8B-4292-9BAE-4D34D1261276Q33987858-0275A2FE-86E7-446F-87B8-6C6B9C7E57BEQ34113522-0EE1AF64-155C-45CB-BC39-36D742A565B0Q34123230-253CD879-B4DE-43A2-918C-ED8772C744CFQ34156342-A048A24B-2A84-44D1-8877-AFA6C2E8E457Q34429758-D92B9F78-47CE-4C1D-859E-87D80E0CBC36Q34470750-3B729838-87DE-4547-A800-1768A37B1DE7Q34475963-12B3F20F-78F6-4317-99CA-994FF6977597Q34549734-B655C1C6-D9DE-48EF-90C2-B81ACCFD2BABQ34681238-B2625F53-2EFD-4684-8C9F-FDB585C9B642Q35097097-6CB560B6-5673-449E-8DDD-F15BC2C5EA37Q35197202-03EA975E-65AF-428D-BEE8-65F7DA5B0781Q35508763-033261BC-8770-451F-B6F7-7918671420A6Q35546019-5D19CBF6-265D-4AC5-91EA-8A22EF010625Q35546751-C896395F-D7C6-47F3-A4DD-28EB94710A2FQ35911335-C2B96CA0-54E7-481A-AA05-BE253122E41BQ36309618-23B9ADC0-D3E1-40FD-BFD7-7719F17651E7Q36408691-0413B966-2A08-406E-A67F-4B8E5EBE9D64Q36443790-48E20E3C-48E7-4097-B100-3572676CB881Q36845787-ED5C5DAB-D5FF-401B-B031-09925F34048AQ36956261-25B7C2BE-8B6B-4771-99C0-510A211F72D5Q37006902-D26F3984-2A1D-47E5-A7F2-41412CFDEE3BQ37015523-AD34B1A9-9B67-445F-BC5B-BF40A4FC01FDQ37111573-4FD1C9FC-60BB-4FD9-B9A0-6819CED13180Q38644509-819D13F2-F586-42E4-9A90-F1DFF2C18578Q38919839-94159248-0DB4-494B-AF08-2D615414B3E4Q39611640-9E12882A-E925-497E-A92F-2431E0073F86Q39825246-E546EDA4-EB6A-4E71-BE5D-402D34B314E8Q41695186-B711107F-B3BB-4158-A278-996116C93261
P2860
Cryptococcus neoformans. II. Phagocytosis by human leukocytes.
description
1967 nî lūn-bûn
@nan
1967年の論文
@ja
1967年学术文章
@wuu
1967年学术文章
@zh-cn
1967年学术文章
@zh-hans
1967年学术文章
@zh-my
1967年学术文章
@zh-sg
1967年學術文章
@yue
1967年學術文章
@zh
1967年學術文章
@zh-hant
name
Cryptococcus neoformans. II. Phagocytosis by human leukocytes.
@en
Cryptococcus neoformans. II. Phagocytosis by human leukocytes.
@nl
type
label
Cryptococcus neoformans. II. Phagocytosis by human leukocytes.
@en
Cryptococcus neoformans. II. Phagocytosis by human leukocytes.
@nl
prefLabel
Cryptococcus neoformans. II. Phagocytosis by human leukocytes.
@en
Cryptococcus neoformans. II. Phagocytosis by human leukocytes.
@nl
P2860
P1476
Cryptococcus neoformans. II. Phagocytosis by human leukocytes.
@en
P2093
P2860
P304
P407
P577
1967-11-01T00:00:00Z